We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UCB Unit Gets Form 483 for Deviation Investigation Shortfalls
UCB Unit Gets Form 483 for Deviation Investigation Shortfalls
February 4, 2013
A pileup of complaints about ineffective drugs produced at Kremers Urban Pharmaceuticals’ Indiana plant appear to be linked to insufficient inquiries into drug defects, a Form 483 states.